Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02780700
Title Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Boehringer Ingelheim
Age Groups: adult
Covered Countries USA

No variant requirements are available.